Clinical Test Report for improving hair loss of 2 Cosmetics

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0005501

Enrollment

Registered

2020-10-20

Start date

2020-09-14

Completion date

Unknown

Last updated

2021-08-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Others : This test includes the random assignment of test products (including valid ingredients) and control products (not valid components). After washing hair three times a week for six months, dry

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: - Volunteer between the ages of 18 and 54 diagnosed with androgenic hair loss. - Patients who will not have special hair products or hair care and manipulation during the study period - Patients who will maintain the same head shape for the duration of the study. - Volunteer who understands the research and voluntarily prepares and signs a consent form to participate in clinical trials. - Volunteer who can be monitored during a test period

Exclusion criteria

Exclusion criteria: - Volunteer suffering from severe acute kidney or heart or other chronic diseases (hypertension, diabetes, etc.) that may affect test results in the last six months. - Volunteer who is pregnant, breast-feeding, or planning to conceive within six months. - A mentally ill person - Volunteer with an infectious skin condition - Volunteer who has undergone surgical treatment for hair loss, such as hair transplantation, scalp reduction, etc. - Those who have been taking the following drugs for the past month: steroids, apoptosis, vascular dilators, anticoagulants, anticorruption agents, beta receptor blockers, bronchial extensions, diuretics, diazoxide, cyclosporine, ketomonazole - Volunteer who has been applying local steroid preparations to the scalp for the past month. - Volunteer who is deemed to have difficulty in applying the test substance due to severe seborrheic dermatitis, psoriasis of the scalp, or infection of the scalp. - In addition to androgenic hair loss, patients with other hair loss diseases such as circular hair loss, tissue hair loss, and semitransparent hair loss. - Any other person deemed unfit for the examination by the person in charge of research.

Design outcomes

Primary

Measure	Time frame
Hair density	—

Secondary

Measure	Time frame
Researcher evaluation by photography;Survey evaluation by test subjects	—

Countries

Korea, Republic of

Contacts

Public ContactYEJIN KIM

Seowon University

ehkais518@naver.com+82-43-299-8185

Outcome results